Product Information
FROVATRIPTAN SUCC 2.5 MG TAB is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $2.7171 per EA under NDC 69238153909. Its NADAC has been published 366 times since Oct 2, 2019.
FDA first approved this application on Nov 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238153909
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FROVATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA211292FDA Approved
11/6/2018
TE Code
AB
On Market Since
11/13/2018
Pharmacological Classes
Price Statistics
The NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has been published 366 times since Oct 2, 2019, and over the history we have for it it has declined 91.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7171 per EA |
|---|---|
| All-time high | $34.9586 (Jan 15, 2020) |
| All-time low | $2.7171 (Sep 23, 2026) |
| 52-week high | $3.6263 |
| 52-week low | $2.7171 |
| Median price | $9.2213 |
| Average price | $12.4900 |
| Largest weekly change | +77.7% (Jun 19, 2024) |
| Weeks tracked | 366 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Frovatriptan succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Frovatriptan succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FROVATRIPTAN SUCC 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FROVATRIPTAN SUCC 2.5 MG TAB, manufactured by Amneal Pharmaceuticals NY LLC, is $2.7171 per EA (NDC 69238153909), effective Sep 30, 2026.
How has the price of FROVATRIPTAN SUCC 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has declined 91.7%. It has been tracked across 366 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for FROVATRIPTAN SUCC 2.5 MG TAB?
Since Oct 2, 2019, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has ranged from a low of $2.7171 (Sep 23, 2026) to a high of $34.9586 (Jan 15, 2020), with a median of $9.2213 per EA.
Are there cheaper alternatives to FROVATRIPTAN SUCC 2.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of FROVATRIPTAN SUCC 2.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FROVATRIPTAN SUCC 2.5 MG TAB?
FROVATRIPTAN SUCC 2.5 MG TAB (NDC 69238153909) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.